Given previous studies demonstrating a potential role of microglia and astrocytes during disease progression of ALS [29–32], and the potential role for HMGB1 in modulating gliosis [33], we also examined glial markers in the pre-onset treatment group. Here, HMGB1 is linked to amyotrophic lateral sclerosis.